Mikram Jafri, Amit Sachdev, Javed Sadiq, David Lee, Ting Taur, Adam Goodman, Frank Gress
{"title":"Efficacy of Endotherapy in the Treatment of Pain Associated With Chronic Pancreatitis: A Systematic Review and Meta-Analysis.","authors":"Mikram Jafri, Amit Sachdev, Javed Sadiq, David Lee, Ting Taur, Adam Goodman, Frank Gress","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Endotherapy is a treatment modality that can be used to manage the pain associated with chronic pancreatitis. The aim of this systematic review and meta-analysis is to evaluate the efficacy of endotherapy in the management of pain associated with chronic pancreatitis.</p><p><strong>Methods: </strong>A search of Medline, Pubmed, and Embase databases between 1988 to December 2014 was conducted to evaluate the use of endotherapy for pain relief in patients with chronic pancreatitis. We included large prospective studies, randomized controlled trials and retrospective analyses. Exclusion criteria included studies not written in the English language, small studies with less than 10 patients, case series/case reports and studies that enrolled patients treated with dual therapies including surgery or celiac plexus neurolysis. In addition, a subgroup analysis was conducted to evaluate studies that included patients with pancreatic duct strictures. A meta-analysis was performed and the data on pain relief was subsequently extracted, pooled, and analyzed. I<sup>2</sup> index estimates were calculated to test for variability and heterogeneity across the included studies.</p><p><strong>Results: </strong>Our final analysis included sixteen studies, comprising 1498 patients. Eleven studies presented data on immediate pain relief after endotherapy and twelve studies presented data on both immediate and long term pain relief (mean follow up was 47.4 months). The compiled result of the sixteen studies for immediate pain relief demonstrated 88% efficacy (95% NT CI [81.0%, 94%]) of endotherapy. Similarly, analysis of pain relief on long term follow-up showed a 67% efficacy of endotherapy (95% NT CI [58%, 76%]). The compiled complication rate for endotherapy in this review was 7.85% per ERCP/endotherapeutic procedure and the most common complications were acute pancreatitis, stent occlusion and stent migration.</p><p><strong>Conclusions: </strong>Endotherapy is beneficial for both immediate and long term management of pain associated with chronic pancreatitis. The efficacy of endotherapy decreases over time as assessed by evaluating pain relief on long term follow up. Given the considerable heterogeneity of reported data, additional prospective and standardized multicenter studies need to be conducted to evaluate the efficacy of this modality in controlling pain associated with chronic pancreatitis.</p>","PeriodicalId":47280,"journal":{"name":"Journal of the Pancreas","volume":"18 2","pages":"125-132"},"PeriodicalIF":0.1000,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619873/pdf/nihms883252.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Pancreas","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/3/30 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Endotherapy is a treatment modality that can be used to manage the pain associated with chronic pancreatitis. The aim of this systematic review and meta-analysis is to evaluate the efficacy of endotherapy in the management of pain associated with chronic pancreatitis.
Methods: A search of Medline, Pubmed, and Embase databases between 1988 to December 2014 was conducted to evaluate the use of endotherapy for pain relief in patients with chronic pancreatitis. We included large prospective studies, randomized controlled trials and retrospective analyses. Exclusion criteria included studies not written in the English language, small studies with less than 10 patients, case series/case reports and studies that enrolled patients treated with dual therapies including surgery or celiac plexus neurolysis. In addition, a subgroup analysis was conducted to evaluate studies that included patients with pancreatic duct strictures. A meta-analysis was performed and the data on pain relief was subsequently extracted, pooled, and analyzed. I2 index estimates were calculated to test for variability and heterogeneity across the included studies.
Results: Our final analysis included sixteen studies, comprising 1498 patients. Eleven studies presented data on immediate pain relief after endotherapy and twelve studies presented data on both immediate and long term pain relief (mean follow up was 47.4 months). The compiled result of the sixteen studies for immediate pain relief demonstrated 88% efficacy (95% NT CI [81.0%, 94%]) of endotherapy. Similarly, analysis of pain relief on long term follow-up showed a 67% efficacy of endotherapy (95% NT CI [58%, 76%]). The compiled complication rate for endotherapy in this review was 7.85% per ERCP/endotherapeutic procedure and the most common complications were acute pancreatitis, stent occlusion and stent migration.
Conclusions: Endotherapy is beneficial for both immediate and long term management of pain associated with chronic pancreatitis. The efficacy of endotherapy decreases over time as assessed by evaluating pain relief on long term follow up. Given the considerable heterogeneity of reported data, additional prospective and standardized multicenter studies need to be conducted to evaluate the efficacy of this modality in controlling pain associated with chronic pancreatitis.
背景:内镜治疗是一种可用于治疗慢性胰腺炎相关疼痛的治疗方式。本系统综述和荟萃分析的目的是评估内镜治疗慢性胰腺炎相关疼痛的疗效。方法:检索1988年至2014年12月Medline、Pubmed和Embase数据库,评估慢性胰腺炎患者使用内镜治疗缓解疼痛的情况。我们纳入了大型前瞻性研究、随机对照试验和回顾性分析。排除标准包括非英文研究、少于10例患者的小型研究、病例系列/病例报告和纳入接受手术或腹腔丛神经松解等双重治疗的患者的研究。此外,还进行了亚组分析,以评估包括胰管狭窄患者的研究。进行了荟萃分析,随后提取、汇总和分析了疼痛缓解的数据。计算I2指数估计值以检验纳入研究的变异性和异质性。结果:我们的最终分析包括16项研究,1498例患者。11项研究报告了内源性治疗后疼痛立即缓解的数据,12项研究报告了即时和长期疼痛缓解的数据(平均随访时间为47.4个月)。16项研究的汇编结果显示,立即缓解疼痛的疗效为88% (95% NT CI[81.0%, 94%])。同样,长期随访的疼痛缓解分析显示,体内治疗的有效率为67% (95% NT CI[58%, 76%])。在本综述中,每个ERCP/内镜治疗手术的并发症发生率为7.85%,最常见的并发症是急性胰腺炎、支架闭塞和支架移位。结论:内镜治疗对慢性胰腺炎相关疼痛的即时和长期治疗都是有益的。在长期随访中,通过评估疼痛缓解程度来评估,内源性治疗的疗效会随着时间的推移而降低。考虑到报告数据的相当大的异质性,需要进行额外的前瞻性和标准化的多中心研究来评估这种模式在控制慢性胰腺炎相关疼痛方面的疗效。